Navigation Links
terna Zentaris Discloses First In Vitro Data for its PI3K,,,Inhibitors at the AACR Annual Meeting in Los Angeles

collected. Several derivatives are currently undergoing first pharmacokinetic in vivo studies.

About terna Zentaris Inc.

terna Zentaris Inc. is a global, pure play biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization.

News releases and additional information are available at www.aeternazentaris.com

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "believes", "anticipates", "intends", "plans", "expects", "estimates", "will," "may", "should", "approximately", and the negative or other variations of those terms or comparable terminology, are forward-looking statements. Such statements reflect management's current views, intentions, strategies and plans and are based on certain assumptions.

Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
7. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
9. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. Common Preterm Labor Drug Has More Side Effects Than Alternative, Finds Study from Packard Childrens Hospital and Stanford

Post Your Comments:
(Date:11/30/2009)...re/ -- Reportlinker.com announces that a new marke..., Cardiac Defibrillators - A Worldwide Market ...r.com/p0164315/Cardiac-Defibrillators---A-Worldwid...scular disease (CVD) is one of the foremost causes...ors are prone to arrhythmic disorders, calling the...
(Date:11/30/2009)...ire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ ), ...documentation services, today announced that it ha...Inc. (Nuance) under which MedQuist will now licens...nd processing software for use in SpeechQ of Gener...nition application for all medical disciplines. S...
(Date:11/30/2009)...re/ -- Reportlinker.com announces that a new marke..., Diabetes Diagnostics - A Global Market Persp...7/Diabetes-Diagnostics---A-Global-Market-Perspecti...n by a steady increase in the number of people dia...veloping parts of the world, and increase in inten...
Breaking Medicine Technology:Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 4Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 5Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 6Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 7Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 8Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 9Dominion Diagnostics Continues To Lead Through On Demand Laboratory Science 14387 1Dominion Diagnostics Continues To Lead Through On Demand Laboratory Science 14387 2Rib X Pharmaceuticals Inc Co Founder Thomas A Steitz Ph D Awarded the 2009 Nobel Prize in Chemistry 5296 1Rib X Pharmaceuticals Inc Co Founder Thomas A Steitz Ph D Awarded the 2009 Nobel Prize in Chemistry 5296 2Rib X Pharmaceuticals Inc Co Founder Thomas A Steitz Ph D Awarded the 2009 Nobel Prize in Chemistry 5296 3Rib X Pharmaceuticals Inc Co Founder Thomas A Steitz Ph D Awarded the 2009 Nobel Prize in Chemistry 5296 4NHLBI awards 2411 million for molecular roadmap to chronic lung diseases 10289 1NHLBI awards 2411 million for molecular roadmap to chronic lung diseases 10289 2
...Robert Figlin Highlights Phase 2 Data Showing 31%,...enefit Rate to Perifosine, Used as a Single Agent... Toxicity When Combined with Soraf...Inc. today announced positive phase 1 & 2 data of ...nal cell carcinoma (RCC). In an oral presentation,...
...routine screening, WASHINGTON, Nov. 8 Today, Tes... for Public Health and the North,Carolina Rules Re...lude the,Centers for Disease Control and Preventio...rt of routine medical care. Now in North Carolina,...nt and pre-test counseling is,no longer required.,...
Other Medicine Technology:Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 2Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 3Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 4Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 5Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 6Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 7Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing 2
(Date:11/30/2009).... 30 Kemin Foods, L.C. ("Kemin") a...tive Health Technologies, Ltd. ("OmniActive") have...The parties agree that Kemin,s US Patent No. 5,382...tion, Purification and Recrystallization of Lutein...of" and the reissues of that patent are valid and ...
(Date:11/30/2009)...ov. 30 American Diversif...eased to announce the appointment of Howard M. Mc...y,s Board of Directors. Mr. McEldowney, whose inve... at the Chemical Bank in New York City and subsequ...McEldowney, San Francisco, an institutional money ...
(Date:11/30/2009)..., PHILADELPHIA, Pennsylvania, November 30 /P...ates From Elsevier,s Top Thought Leaders Provide I..., Elsevier, a world leader in healthcare publ...tronic health record (EHR) integrated solutions, t...erican Recovery and Reinvestment,Act (ARRA) update...
(Date:11/30/2009)...ntrol and Prevention estimate that well over one m...th HIV/AIDS. New research from North Carolina Stat... minorities and do not have health insurance, and ...ilitate education and prevention efforts in minori...hich analyzed 90,000 HIV patient hospital visits o...
(Date:11/30/2009)...tal has launched a series of clinical trials in or...atment. This approach involves the application of ...mour cells from the patient him or herself and des...ressive and frequent malignant tumours. The new th...mbined with the standard, first-line treatment inv...
Breaking Medicine News(10 mins):Health News:American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 3Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 4Health News:Research highlights need for national HIV strategy 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6
... Viagrabulk.com is a leading online s...elp for children who are suffering from pulmonary ...Mumbai, Maharashtra (PRWEB) November 3, 2008 -- Vi...Nitric Oxide (INO) treatment is considered as the ...
... 113 children and teens physically victimized by p... to safely avoid conflict and diffuse threats make...guidance is initiated in the immediate aftermath o...ducted on 10- to 15-year-olds treated for assault ...
... it safe and using a two-pronged attack, a novel d... created and tested by an international team of re...e hand, the substance is similar to components of ..., the novel molecule also puts pressure on the tum...
...ic resonance elastography, it could eliminate need...ov. 1 (HealthDay News) -- A new imaging technology...highly accurate in identifying liver diseases and ...ded images (elastograms) that indicate how interna...
..., Ill. A study in the Nov. 1 issue of the journal...neurochemical abnormality in adults with primary i...understanding of the condition,s pathology. , Re...s who have been suffering from primary insomnia fo...
... Origin 100% Pure Ceylon Teas Warm Up Crisp Autumn...rmet Tea Lovers in Your Life, JACKSONVILLE, Fla.,...is the ideal complement to crisp autumn mornings a...and,satisfying hand picked "tea lover" classics fr...
Other Medicine News:Health News:Viagra Bulk Effectively Cures Children with PAH (Pulmonary Arterial Hypertension) 2Health News:Memo to ER docs: Send young victims of violence for 1-on-1 counseling 2Health News:Memo to ER docs: Send young victims of violence for 1-on-1 counseling 3Health News:Substance tackles skin cancer from 2 sides 2Health News:New Imaging Identifies Types of Liver Disease 2Health News:Study links primary insomnia to a neurochemical abnormality in young and middle-aged adults 2Health News:Study links primary insomnia to a neurochemical abnormality in young and middle-aged adults 3Health News:Cook to a Tea 2
...m consists of a pistol-grip handpiece available in...e range of couplers that can be used in a variety ...SmartDriver. Modular Pistol-Grip instrument used i...module for drilling, pinning, cutting, and debride...
...m consists of a pistol-grip handpiece available in...e range of couplers that can be used in a variety ...y SmartDriver XT offers significantly increased to...artDriver. The Battery SmartDriver XT accepts the ...
Series 7000 Battery/Electric Large Bone System
...ue Repair System is an evolutionary product for th...gh initially designed specifically for use with th...r is quickly becoming a new standard for use in me...ue method to deliver sutures using a patented deli...
Medicine Products: